McCulloch Kevin sold XERS

August 1, 2026 · Form 4 insider transaction

McCulloch Kevin sold 21,918 shares of Xeris Biopharma Holdings, Inc. at $8.08 per share, a transaction worth $177.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 20 days after the transaction.

Direction
Disposed (sell-side)
Shares
21,918
Price
$8.08
Total value
$177.1K
Role
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateAugust 1, 2026
Filing dateAugust 21, 2026
Shares owned after1,654,208
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of August 1, 2026.

View the original Form 4 on SEC EDGAR